Science Translational Medicine announces the addition of twelve early-career translational scientists who will serve a one-year term as Associate Scientific Advisors for the journal. Starting mid-January, the Associate Scientific Advisors will write Editor's Choice articles and consult with Science Translational Medicine editors on research in their respective fields of study.
"The Science Translational Medicine editors selected these twelve participants from more than 30 nominees for their insight into selection of an appropriate article, their clarity of thought, and their diverse backgrounds to cover important fields in clinical and translational science," said Cynthia Morris, Professor of Medicine, Public Health and Preventative Medicine at Oregon Health & Science University, who helped with the selection.
Eligible participants were post doctoral scholars who are active in the Clinical and Translational Science Award (CTSA) education or career development programs. A consortium developed by the National Institutes of Health, the CTSA program aims to create an academic home for clinical and translational research at institutions across the United States. Science Translational Medicine editors invited CTSA principal investigators and mentors to nominate outstanding CTSA early-career scientists to become Associate Scientific Advisors.
"One of our goals is that Science Translational Medicine helps to bring together diverse members of the translational medicine community. And our Chief Scientific Advisor, Elias Zerhouni, is committed to having young scientists be involved with the journal," said LaMarco, Senior Editor for Science Translational Medicine.
In the Editor's Choice section of the journal, the Associate Scientific Advisors will cover and provide perspective on a broad range of topics in articles from many specialty journalsfurthering the interdisciplinary mission of transla
|Contact: Natasha Pinol|
American Association for the Advancement of Science